AbbVie News - ABBV

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
AbbVie Inc ABBV NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
3.17 4.2% 78.56 74.7819 78.98 76.44 75.39 20:00:00
more quote information »

Recent News

Date Time Source Heading
4/08/202010:57DJNForm 8.3 - [Allergan Plc]
4/07/202009:45DJNForm 8.3 - [Allergan Plc]
4/07/202009:09EDGARNotice of Exempt Solicitation. Definitive Material...
4/06/202011:50DJNForm 8.3 - [Allergan Plc]
4/06/202008:09EDGARCurrent Report Filing (8-k)
4/06/202008:00PRNUSAbbVie Announces Extension of Expiration Date for Exchange..
4/03/202010:37DJNForm 8.3 - [Allergan Plc]
4/02/202017:04EDGARStatement of Changes in Beneficial Ownership (4)
4/02/202017:03EDGARStatement of Changes in Beneficial Ownership (4)
4/02/202017:02EDGARStatement of Changes in Beneficial Ownership (4)
4/02/202017:02EDGARStatement of Changes in Beneficial Ownership (4)
4/02/202008:00PRNUSAbbVie to Host First-Quarter 2020 Earnings Conference Call
4/01/202011:17DJNForm 8.3 - [Allergan Plc]
3/31/202019:24PRNUSAbbVie Donates $35 Million for COVID-19 Relief to Support..
3/27/202010:48DJNForm 8.3 - [Allergan Plc]
3/26/202012:10DJNForm 8.3 - [Allergan Plc]
3/26/202006:07EDGARNotice of Exempt Solicitation. Definitive Material...
3/25/202011:19DJNForm 8.3 - Allergan Plc
3/24/202009:58DJNForm 8.3 - [Allergan Plc]
3/24/202006:01EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/23/202017:23EDGARProxy Statement (definitive) (def 14a)
3/23/202010:59DJNForm 8.3 - [Allergan Plc]
3/23/202009:28DJNAbbVie Says Acute Myeloid Leukemia Trial Meets Endpoints
3/23/202008:14EDGARCurrent Report Filing (8-k)
3/23/202008:00PRNUSAbbVie Announces Positive Topline Results from Phase 3 Trial..
3/20/202017:35EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
3/20/202016:57EDGARStatement of Changes in Beneficial Ownership (4)
3/20/202011:17DJNForm 8.3 - [Allergan Plc]
3/19/202011:19DJNForm 8.3 - [Allergan Plc]
3/18/202010:43DJNForm 8.3 - [Allergan plc ]
3/17/202016:30PRNUSAbbVie and Allergan Sign Consent Decree Agreement with..
3/16/202010:48DJNForm 8.3 - [Allergan plc]
3/13/202010:23DJNForm 8.3 - [Allergan plc]
3/12/202011:03DJNForm 8.3 - [Allergan Plc]
3/12/202007:00PRNUSAbbVie Receives European Commission Approval of VENCLYXTO®..
3/11/202013:07PRNCAAbbVie annonce l'inscription de SKYRIZI® à d'autres listes..
3/11/202010:52DJNForm 8.3 - [Allergan plc]
3/10/202010:48DJNForm 8.3 - [Allergan plc]
3/09/202017:19EDGARProxy Statement - Notice of Shareholders Meeting..
3/09/202011:47DJNForm 8.3 - Allergan Plc
3/09/202009:54DJNAbbVie Says It Can't Confirm Reports About Efficacy Of Drug..
3/09/202009:45EDGARCurrent Report Filing (8-k)
3/09/202009:36PRNUSAbbVie Announces Extension of Expiration Date for Exchange..
3/09/202008:45PRNUSAbbVie Partnering with Global Authorities to Determine..
3/09/202007:43DJNBristol Myers Phase 3 Empliciti Study Misses Primary..
3/06/202010:14DJNForm 8.3 - Allergan Plc
3/06/202007:43DJNAbbVie Gets European Commission Approval to Shorten Maviret..
3/06/202007:00PRNUSEuropean Commission Grants AbbVie Marketing Authorization..
3/05/202010:35DJNForm 8.3 - Allergan Plc
3/04/202017:15EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »
Your Recent History
NYSE
ABBV
AbbVie
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200409 00:51:46